Mereo BioPharma Group plc (MAH0) — Free Cash Flow Generation Index
Latest as of September 2023:
1.00x
Mereo BioPharma Group plc (MAH0) has a Free Cash Flow Generation Index of 1.00x as of September 2023. Free cash flow of €2.66 Million represents 1% of operating cash flow (€2.66 Million). Explore Mereo BioPharma Group plc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
€2.66 Million
EUR
Operating Cash Flow
€2.66 Million
EUR
Capital Expenditures
€0.00
EUR
Annual Free Cash Flow Generation for Mereo BioPharma Group plc (None–None)
Year-by-year Free Cash Flow Generation Index for Mereo BioPharma Group plc. Check MAH0 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).